New Mpox Drug Trial Fails: What This Means for Future Treatments in 2024

Oh, joy—another promising drug for mpox has crashed and burned in trials. If you were counting on this latest miracle pill to save the day, you might want to start recalibrating your expectations. The drug, which was supposed to be a game-changer, has now proven to be about as effective as a placebo in a candy store. So, if you're still clinging to the hope that pharmaceutical miracles are just around the corner, it’s time to face reality.

In the latest chapter of "How to Disappoint Patients," this trial’s outcome just reinforces the fact that we might be better off with a lucky rabbit’s foot than relying on these so-called breakthroughs. The new failure is sure to make headlines in the ongoing saga of "Why We Can't Have Nice Things" and leave you pondering why you ever trusted in the first place.

To top it off, this drug’s epic fail is a reminder that we’re all just spectators in a high-stakes game of pharmaceutical roulette. So, while you wait for the next "promising" drug to miss the mark, take comfort in knowing that disappointment is always just a trial away.

For the full details of this latest letdown, check out the article [here](https://www.wired.com/story/a-promising-drug-for-mpox-just-failed-in-trials/).